fbpx
我们正在寻找中国人参与临床研究
News
AKL & HAM - 0800 788 3437
CHC & WLG - 0800 862 278

Important Information

Please note, we need you to ….
  • Read the important documents for this study
  • If you are interested, look at the dates that this study is being run (cohort visit planners) and  reply to our email (don’t re-register online) to let us know which cohort(s) you are available for
  • We will ring you to check your suitability and provide further information about the study
  • We will make you a screening appointment at NZCR Auckland. You will need to attend at the scheduled time if you wish to take part in the study

Study Information

New Zealand Clinical Research is trialling an experimental medication that is being developed for the treatment of Chronic Hepatitis B (CHB).

Chronic infections with Hepatitis B Virus (HBV) can result in liver damage, leading to liver failure and potentially liver cancer. AB-101 is being developed for the treatment of HBV infection in people who have developed CHB.

AB-101 works by promoting the body’s immune system (defence mechanism) cells to target and destroy HBV cells. To hopefully reduce the level of HBV cells within the body to provide a functional cure for CHB.

This study will investigate the effects of AB-101 in healthy participants Part 1 (SAD) and Part 2 (MAD).

It is an experimental drug because it has not been approved by MedSafe or other drug regulatory authorities.

This study (2023 FULL 18214) is being funded by Arbutus Biopharma Corporation and has been approved by the Health and Disability Ethics Committee.

Study Candidates

  • Healthy Males only
    • BMI 18 – 35 kg/m2
    • Non-smokers or Ex-smokers
    • Not currently taking any medications

What is Involved?

Spring SAD

Study Visits: 4-night stay

Outpatient visits: 7 visits

Reimbursement: $4,500 (less tax)

Important Documents

Important documents to download and read

Pre-screening Form

Spring

Pre screening for Spring

Personal details

Please provide your name, email and phone number so we can contact you

Medical questions

Have you had any covid symptoms in the last two weeks or been in isolation?
Have you previously participated in a study with NZCR or any other organisation? Give details or leave blank if no
This study requires the use of contraception during the study. If you are in a hetereosexual relationship both partners must agree to use contraception (condoms for males | IUD, birth control or another approved form for female partners). Are you currently using 2 forms of contraception?
Have you smoked or vaped in the last 90 days ?(Required)
Do you have any history of medical, psychiatric, or neurodevelopmental conditions? This includes things like ADHD, autism, tourettes, bipolar disorder, depression etc
Do you have any history of medical conditions relating to:
Have you donated blood or plasma in the last few months?
If unsure please note down what vaccines you have had in the last 6 months and when.
Do you have any history of allergies, asthma, hay fever, food allergies etc that you are aware of?
Have you taken any prescription, vitamins, supplements, pharmacy medication or over the counter medications in the last 14 days?
Have you looked at the study dates and are okay to come in those days? Indicate which group/s you are available for. Flexibility for other groups increases your chances of getting into the study.
Screening Conditions(Required)
Just to inform you, that you come in for screening at risk. There is no payment for the screening visit, and you may not be offered a position on the study if the group fills up, or you may only be offered a position as a back-up. It is not guaranteed that you will get a full position on the study as it depends on your results as well. Are you comfortable with this?